nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—OPRD1—coronary artery disease	0.201	0.714	CbGaD
Buprenorphine—CYP2C19—coronary artery disease	0.0802	0.286	CbGaD
Buprenorphine—ABCG2—Pitavastatin—coronary artery disease	0.0136	0.0283	CbGbCtD
Buprenorphine—ABCG2—Telmisartan—coronary artery disease	0.0136	0.0283	CbGbCtD
Buprenorphine—CYP2C8—Fenofibrate—coronary artery disease	0.0119	0.0249	CbGbCtD
Buprenorphine—CYP3A7—Eplerenone—coronary artery disease	0.0107	0.0222	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0107	0.0222	CbGbCtD
Buprenorphine—ABCG2—Rosuvastatin—coronary artery disease	0.01	0.0209	CbGbCtD
Buprenorphine—ABCG2—Ezetimibe—coronary artery disease	0.01	0.0209	CbGbCtD
Buprenorphine—CYP2C8—Gemfibrozil—coronary artery disease	0.00954	0.0199	CbGbCtD
Buprenorphine—ABCG2—Pravastatin—coronary artery disease	0.0091	0.019	CbGbCtD
Buprenorphine—ABCB1—Ticagrelor—coronary artery disease	0.00906	0.0189	CbGbCtD
Buprenorphine—CYP3A5—Clopidogrel—coronary artery disease	0.0086	0.0179	CbGbCtD
Buprenorphine—CYP2C9—Fenofibrate—coronary artery disease	0.00832	0.0174	CbGbCtD
Buprenorphine—CYP2C8—Clopidogrel—coronary artery disease	0.00827	0.0173	CbGbCtD
Buprenorphine—CYP2C19—Gemfibrozil—coronary artery disease	0.008	0.0167	CbGbCtD
Buprenorphine—CYP3A5—Eplerenone—coronary artery disease	0.008	0.0167	CbGbCtD
Buprenorphine—CYP1A2—Gemfibrozil—coronary artery disease	0.00739	0.0154	CbGbCtD
Buprenorphine—CYP2C8—Pitavastatin—coronary artery disease	0.00723	0.0151	CbGbCtD
Buprenorphine—CYP2C19—Clopidogrel—coronary artery disease	0.00694	0.0145	CbGbCtD
Buprenorphine—CYP3A7—Simvastatin—coronary artery disease	0.00687	0.0143	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.00687	0.0143	CbGbCtD
Buprenorphine—CYP3A7—Lovastatin—coronary artery disease	0.00672	0.014	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.00672	0.014	CbGbCtD
Buprenorphine—CYP2C9—Gemfibrozil—coronary artery disease	0.00665	0.0139	CbGbCtD
Buprenorphine—CYP1A2—Clopidogrel—coronary artery disease	0.0064	0.0134	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.00612	0.0128	CbGbCtD
Buprenorphine—CYP3A7—Atorvastatin—coronary artery disease	0.00612	0.0128	CbGbCtD
Buprenorphine—CYP2C19—Telmisartan—coronary artery disease	0.00607	0.0127	CbGbCtD
Buprenorphine—CYP2C9—Clopidogrel—coronary artery disease	0.00577	0.012	CbGbCtD
Buprenorphine—ABCB1—Perindopril—coronary artery disease	0.0056	0.0117	CbGbCtD
Buprenorphine—ABCB1—Clopidogrel—coronary artery disease	0.0056	0.0117	CbGbCtD
Buprenorphine—CYP3A5—Rosuvastatin—coronary artery disease	0.00554	0.0116	CbGbCtD
Buprenorphine—CYP3A4—Ticagrelor—coronary artery disease	0.00543	0.0113	CbGbCtD
Buprenorphine—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00519	0.0108	CbGbCtD
Buprenorphine—CYP3A5—Simvastatin—coronary artery disease	0.00515	0.0108	CbGbCtD
Buprenorphine—CYP3A5—Pravastatin—coronary artery disease	0.00504	0.0105	CbGbCtD
Buprenorphine—CYP3A5—Lovastatin—coronary artery disease	0.00504	0.0105	CbGbCtD
Buprenorphine—CYP2C9—Pitavastatin—coronary artery disease	0.00504	0.0105	CbGbCtD
Buprenorphine—CYP2C8—Simvastatin—coronary artery disease	0.00496	0.0103	CbGbCtD
Buprenorphine—CYP2C9—Valsartan—coronary artery disease	0.00491	0.0102	CbGbCtD
Buprenorphine—ABCB1—Pitavastatin—coronary artery disease	0.00489	0.0102	CbGbCtD
Buprenorphine—ABCB1—Telmisartan—coronary artery disease	0.00489	0.0102	CbGbCtD
Buprenorphine—CYP2C19—Timolol—coronary artery disease	0.00489	0.0102	CbGbCtD
Buprenorphine—CYP2C8—Pravastatin—coronary artery disease	0.00485	0.0101	CbGbCtD
Buprenorphine—CYP2C8—Lovastatin—coronary artery disease	0.00485	0.0101	CbGbCtD
Buprenorphine—CYP3A4—Fenofibrate—coronary artery disease	0.00484	0.0101	CbGbCtD
Buprenorphine—ABCB1—Enalapril—coronary artery disease	0.00464	0.00968	CbGbCtD
Buprenorphine—ABCB1—Lisinopril—coronary artery disease	0.00464	0.00968	CbGbCtD
Buprenorphine—CYP3A5—Atorvastatin—coronary artery disease	0.00459	0.00958	CbGbCtD
Buprenorphine—CYP2C19—Rosuvastatin—coronary artery disease	0.00447	0.00933	CbGbCtD
Buprenorphine—CYP2C8—Atorvastatin—coronary artery disease	0.00442	0.00921	CbGbCtD
Buprenorphine—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00436	0.00909	CbGbCtD
Buprenorphine—CYP3A5—Losartan—coronary artery disease	0.0042	0.00876	CbGbCtD
Buprenorphine—CYP2C19—Simvastatin—coronary artery disease	0.00416	0.00867	CbGbCtD
Buprenorphine—CYP2C19—Lovastatin—coronary artery disease	0.00407	0.00849	CbGbCtD
Buprenorphine—CYP2C8—Losartan—coronary artery disease	0.00404	0.00843	CbGbCtD
Buprenorphine—CYP2D6—Niacin—coronary artery disease	0.004	0.00834	CbGbCtD
Buprenorphine—ABCB1—Timolol—coronary artery disease	0.00394	0.00823	CbGbCtD
Buprenorphine—CYP3A4—Gemfibrozil—coronary artery disease	0.00387	0.00807	CbGbCtD
Buprenorphine—CYP2C9—Rosuvastatin—coronary artery disease	0.00372	0.00776	CbGbCtD
Buprenorphine—CYP2D6—Timolol—coronary artery disease	0.00372	0.00775	CbGbCtD
Buprenorphine—CYP2C19—Atorvastatin—coronary artery disease	0.00371	0.00773	CbGbCtD
Buprenorphine—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00362	0.00756	CbGbCtD
Buprenorphine—ABCB1—Ezetimibe—coronary artery disease	0.00361	0.00753	CbGbCtD
Buprenorphine—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00352	0.00733	CbGbCtD
Buprenorphine—ABCB1—Captopril—coronary artery disease	0.00347	0.00725	CbGbCtD
Buprenorphine—CYP2C9—Simvastatin—coronary artery disease	0.00346	0.00721	CbGbCtD
Buprenorphine—CYP2C19—Losartan—coronary artery disease	0.00339	0.00707	CbGbCtD
Buprenorphine—CYP2C9—Pravastatin—coronary artery disease	0.00338	0.00706	CbGbCtD
Buprenorphine—CYP2C9—Lovastatin—coronary artery disease	0.00338	0.00706	CbGbCtD
Buprenorphine—CYP3A4—Clopidogrel—coronary artery disease	0.00335	0.007	CbGbCtD
Buprenorphine—ABCB1—Simvastatin—coronary artery disease	0.00335	0.007	CbGbCtD
Buprenorphine—ABCB1—Lovastatin—coronary artery disease	0.00328	0.00685	CbGbCtD
Buprenorphine—ABCB1—Pravastatin—coronary artery disease	0.00328	0.00685	CbGbCtD
Buprenorphine—CYP2D6—Captopril—coronary artery disease	0.00327	0.00683	CbGbCtD
Buprenorphine—CYP2D6—Simvastatin—coronary artery disease	0.00316	0.00659	CbGbCtD
Buprenorphine—CYP1A2—Losartan—coronary artery disease	0.00313	0.00652	CbGbCtD
Buprenorphine—CYP3A4—Eplerenone—coronary artery disease	0.00312	0.00651	CbGbCtD
Buprenorphine—CYP2D6—Lovastatin—coronary artery disease	0.00309	0.00645	CbGbCtD
Buprenorphine—CYP2D6—Pravastatin—coronary artery disease	0.00309	0.00645	CbGbCtD
Buprenorphine—CYP2C9—Atorvastatin—coronary artery disease	0.00308	0.00643	CbGbCtD
Buprenorphine—ABCB1—Atorvastatin—coronary artery disease	0.00299	0.00624	CbGbCtD
Buprenorphine—CYP2C9—Losartan—coronary artery disease	0.00282	0.00588	CbGbCtD
Buprenorphine—CYP2D6—Atorvastatin—coronary artery disease	0.00282	0.00588	CbGbCtD
Buprenorphine—CYP3A4—Enalapril—coronary artery disease	0.00278	0.0058	CbGbCtD
Buprenorphine—ABCB1—Losartan—coronary artery disease	0.00273	0.0057	CbGbCtD
Buprenorphine—CYP3A4—Ezetimibe—coronary artery disease	0.00216	0.00451	CbGbCtD
Buprenorphine—CYP3A4—Rosuvastatin—coronary artery disease	0.00216	0.00451	CbGbCtD
Buprenorphine—CYP3A4—Simvastatin—coronary artery disease	0.00201	0.00419	CbGbCtD
Buprenorphine—CYP3A4—Lovastatin—coronary artery disease	0.00197	0.0041	CbGbCtD
Buprenorphine—CYP3A4—Pravastatin—coronary artery disease	0.00197	0.0041	CbGbCtD
Buprenorphine—CYP3A4—Atorvastatin—coronary artery disease	0.00179	0.00374	CbGbCtD
Buprenorphine—CYP3A4—Losartan—coronary artery disease	0.00164	0.00342	CbGbCtD
Buprenorphine—Naloxone—CREB1—coronary artery disease	0.000803	0.243	CrCbGaD
Buprenorphine—Butorphanol—OPRD1—coronary artery disease	0.000576	0.174	CrCbGaD
Buprenorphine—Nalbuphine—OPRD1—coronary artery disease	0.000527	0.16	CrCbGaD
Buprenorphine—Oxymorphone—OPRD1—coronary artery disease	0.00043	0.13	CrCbGaD
Buprenorphine—Naltrexone—OPRD1—coronary artery disease	0.00043	0.13	CrCbGaD
Buprenorphine—Naloxone—OPRD1—coronary artery disease	0.000314	0.0949	CrCbGaD
Buprenorphine—Naloxone—ESR1—coronary artery disease	0.000156	0.0473	CrCbGaD
Buprenorphine—Naloxone—ALB—coronary artery disease	6.95e-05	0.021	CrCbGaD
Buprenorphine—Asthenia—Niacin—coronary artery disease	4.01e-05	0.000271	CcSEcCtD
Buprenorphine—Fatigue—Losartan—coronary artery disease	4e-05	0.000271	CcSEcCtD
Buprenorphine—Headache—Ezetimibe—coronary artery disease	4e-05	0.00027	CcSEcCtD
Buprenorphine—Malaise—Lisinopril—coronary artery disease	3.99e-05	0.00027	CcSEcCtD
Buprenorphine—Oedema—Ramipril—coronary artery disease	3.98e-05	0.000269	CcSEcCtD
Buprenorphine—Anaphylactic shock—Ramipril—coronary artery disease	3.98e-05	0.000269	CcSEcCtD
Buprenorphine—Vertigo—Lisinopril—coronary artery disease	3.98e-05	0.000269	CcSEcCtD
Buprenorphine—Dry mouth—Timolol—coronary artery disease	3.97e-05	0.000269	CcSEcCtD
Buprenorphine—Constipation—Losartan—coronary artery disease	3.97e-05	0.000269	CcSEcCtD
Buprenorphine—Pain—Losartan—coronary artery disease	3.97e-05	0.000269	CcSEcCtD
Buprenorphine—Syncope—Lisinopril—coronary artery disease	3.97e-05	0.000268	CcSEcCtD
Buprenorphine—Vomiting—Eplerenone—coronary artery disease	3.97e-05	0.000268	CcSEcCtD
Buprenorphine—Feeling abnormal—Furosemide—coronary artery disease	3.97e-05	0.000268	CcSEcCtD
Buprenorphine—Nausea—Fenofibrate—coronary artery disease	3.96e-05	0.000267	CcSEcCtD
Buprenorphine—Pruritus—Niacin—coronary artery disease	3.95e-05	0.000267	CcSEcCtD
Buprenorphine—Asthenia—Pravastatin—coronary artery disease	3.94e-05	0.000267	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Furosemide—coronary artery disease	3.94e-05	0.000266	CcSEcCtD
Buprenorphine—Rash—Eplerenone—coronary artery disease	3.94e-05	0.000266	CcSEcCtD
Buprenorphine—Urticaria—Perindopril—coronary artery disease	3.93e-05	0.000266	CcSEcCtD
Buprenorphine—Hypersensitivity—Trandolapril—coronary artery disease	3.93e-05	0.000266	CcSEcCtD
Buprenorphine—Dermatitis—Eplerenone—coronary artery disease	3.93e-05	0.000266	CcSEcCtD
Buprenorphine—Diarrhoea—Valsartan—coronary artery disease	3.93e-05	0.000266	CcSEcCtD
Buprenorphine—Confusional state—Timolol—coronary artery disease	3.93e-05	0.000265	CcSEcCtD
Buprenorphine—Shock—Ramipril—coronary artery disease	3.92e-05	0.000265	CcSEcCtD
Buprenorphine—Hypersensitivity—Enalapril—coronary artery disease	3.92e-05	0.000265	CcSEcCtD
Buprenorphine—Abdominal pain—Perindopril—coronary artery disease	3.91e-05	0.000265	CcSEcCtD
Buprenorphine—Body temperature increased—Perindopril—coronary artery disease	3.91e-05	0.000265	CcSEcCtD
Buprenorphine—Palpitations—Lisinopril—coronary artery disease	3.91e-05	0.000264	CcSEcCtD
Buprenorphine—Diarrhoea—Olmesartan—coronary artery disease	3.91e-05	0.000264	CcSEcCtD
Buprenorphine—Headache—Eplerenone—coronary artery disease	3.91e-05	0.000264	CcSEcCtD
Buprenorphine—Nervous system disorder—Ramipril—coronary artery disease	3.91e-05	0.000264	CcSEcCtD
Buprenorphine—Anaphylactic shock—Timolol—coronary artery disease	3.89e-05	0.000263	CcSEcCtD
Buprenorphine—Oedema—Timolol—coronary artery disease	3.89e-05	0.000263	CcSEcCtD
Buprenorphine—Pruritus—Pravastatin—coronary artery disease	3.89e-05	0.000263	CcSEcCtD
Buprenorphine—Loss of consciousness—Lisinopril—coronary artery disease	3.89e-05	0.000263	CcSEcCtD
Buprenorphine—Nausea—Clopidogrel—coronary artery disease	3.89e-05	0.000263	CcSEcCtD
Buprenorphine—Tachycardia—Ramipril—coronary artery disease	3.89e-05	0.000263	CcSEcCtD
Buprenorphine—Skin disorder—Ramipril—coronary artery disease	3.87e-05	0.000262	CcSEcCtD
Buprenorphine—Infection—Timolol—coronary artery disease	3.87e-05	0.000262	CcSEcCtD
Buprenorphine—Vomiting—Simvastatin—coronary artery disease	3.87e-05	0.000261	CcSEcCtD
Buprenorphine—Hypersensitivity—Telmisartan—coronary artery disease	3.86e-05	0.000261	CcSEcCtD
Buprenorphine—Cough—Lisinopril—coronary artery disease	3.86e-05	0.000261	CcSEcCtD
Buprenorphine—Nausea—Lovastatin—coronary artery disease	3.86e-05	0.000261	CcSEcCtD
Buprenorphine—Hyperhidrosis—Ramipril—coronary artery disease	3.85e-05	0.00026	CcSEcCtD
Buprenorphine—Rash—Simvastatin—coronary artery disease	3.83e-05	0.000259	CcSEcCtD
Buprenorphine—Dermatitis—Simvastatin—coronary artery disease	3.83e-05	0.000259	CcSEcCtD
Buprenorphine—Asthenia—Trandolapril—coronary artery disease	3.83e-05	0.000259	CcSEcCtD
Buprenorphine—Shock—Timolol—coronary artery disease	3.83e-05	0.000259	CcSEcCtD
Buprenorphine—Feeling abnormal—Losartan—coronary artery disease	3.83e-05	0.000259	CcSEcCtD
Buprenorphine—Urticaria—Furosemide—coronary artery disease	3.82e-05	0.000259	CcSEcCtD
Buprenorphine—Diarrhoea—Niacin—coronary artery disease	3.82e-05	0.000258	CcSEcCtD
Buprenorphine—Nervous system disorder—Timolol—coronary artery disease	3.82e-05	0.000258	CcSEcCtD
Buprenorphine—Asthenia—Enalapril—coronary artery disease	3.82e-05	0.000258	CcSEcCtD
Buprenorphine—Headache—Simvastatin—coronary artery disease	3.81e-05	0.000258	CcSEcCtD
Buprenorphine—Abdominal pain—Furosemide—coronary artery disease	3.81e-05	0.000257	CcSEcCtD
Buprenorphine—Body temperature increased—Furosemide—coronary artery disease	3.81e-05	0.000257	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Losartan—coronary artery disease	3.8e-05	0.000257	CcSEcCtD
Buprenorphine—Dizziness—Valsartan—coronary artery disease	3.8e-05	0.000257	CcSEcCtD
Buprenorphine—Anorexia—Ramipril—coronary artery disease	3.8e-05	0.000257	CcSEcCtD
Buprenorphine—Nausea—Ezetimibe—coronary artery disease	3.79e-05	0.000256	CcSEcCtD
Buprenorphine—Skin disorder—Timolol—coronary artery disease	3.78e-05	0.000256	CcSEcCtD
Buprenorphine—Dizziness—Olmesartan—coronary artery disease	3.78e-05	0.000256	CcSEcCtD
Buprenorphine—Pruritus—Trandolapril—coronary artery disease	3.78e-05	0.000255	CcSEcCtD
Buprenorphine—Chest pain—Lisinopril—coronary artery disease	3.77e-05	0.000255	CcSEcCtD
Buprenorphine—Myalgia—Lisinopril—coronary artery disease	3.77e-05	0.000255	CcSEcCtD
Buprenorphine—Arthralgia—Lisinopril—coronary artery disease	3.77e-05	0.000255	CcSEcCtD
Buprenorphine—Hyperhidrosis—Timolol—coronary artery disease	3.76e-05	0.000254	CcSEcCtD
Buprenorphine—Asthenia—Telmisartan—coronary artery disease	3.76e-05	0.000254	CcSEcCtD
Buprenorphine—Pruritus—Enalapril—coronary artery disease	3.76e-05	0.000254	CcSEcCtD
Buprenorphine—Diarrhoea—Pravastatin—coronary artery disease	3.76e-05	0.000254	CcSEcCtD
Buprenorphine—Anxiety—Lisinopril—coronary artery disease	3.75e-05	0.000254	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	3.74e-05	0.000253	CcSEcCtD
Buprenorphine—Discomfort—Lisinopril—coronary artery disease	3.72e-05	0.000252	CcSEcCtD
Buprenorphine—Hypotension—Ramipril—coronary artery disease	3.72e-05	0.000252	CcSEcCtD
Buprenorphine—Anorexia—Timolol—coronary artery disease	3.71e-05	0.000251	CcSEcCtD
Buprenorphine—Pruritus—Telmisartan—coronary artery disease	3.71e-05	0.000251	CcSEcCtD
Buprenorphine—Nausea—Eplerenone—coronary artery disease	3.71e-05	0.000251	CcSEcCtD
Buprenorphine—Dizziness—Niacin—coronary artery disease	3.69e-05	0.00025	CcSEcCtD
Buprenorphine—Urticaria—Losartan—coronary artery disease	3.69e-05	0.000249	CcSEcCtD
Buprenorphine—Dry mouth—Lisinopril—coronary artery disease	3.69e-05	0.000249	CcSEcCtD
Buprenorphine—Abdominal pain—Losartan—coronary artery disease	3.67e-05	0.000248	CcSEcCtD
Buprenorphine—Body temperature increased—Losartan—coronary artery disease	3.67e-05	0.000248	CcSEcCtD
Buprenorphine—Asthenia—Captopril—coronary artery disease	3.66e-05	0.000247	CcSEcCtD
Buprenorphine—Diarrhoea—Trandolapril—coronary artery disease	3.65e-05	0.000247	CcSEcCtD
Buprenorphine—Vomiting—Valsartan—coronary artery disease	3.65e-05	0.000247	CcSEcCtD
Buprenorphine—Confusional state—Lisinopril—coronary artery disease	3.64e-05	0.000246	CcSEcCtD
Buprenorphine—Diarrhoea—Enalapril—coronary artery disease	3.64e-05	0.000246	CcSEcCtD
Buprenorphine—Hypotension—Timolol—coronary artery disease	3.64e-05	0.000246	CcSEcCtD
Buprenorphine—Dizziness—Pravastatin—coronary artery disease	3.64e-05	0.000246	CcSEcCtD
Buprenorphine—Vomiting—Olmesartan—coronary artery disease	3.63e-05	0.000246	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Ramipril—coronary artery disease	3.63e-05	0.000245	CcSEcCtD
Buprenorphine—Rash—Valsartan—coronary artery disease	3.62e-05	0.000245	CcSEcCtD
Buprenorphine—Dermatitis—Valsartan—coronary artery disease	3.62e-05	0.000245	CcSEcCtD
Buprenorphine—Nausea—Simvastatin—coronary artery disease	3.61e-05	0.000244	CcSEcCtD
Buprenorphine—Anaphylactic shock—Lisinopril—coronary artery disease	3.61e-05	0.000244	CcSEcCtD
Buprenorphine—Oedema—Lisinopril—coronary artery disease	3.61e-05	0.000244	CcSEcCtD
Buprenorphine—Pruritus—Captopril—coronary artery disease	3.61e-05	0.000244	CcSEcCtD
Buprenorphine—Rash—Olmesartan—coronary artery disease	3.6e-05	0.000244	CcSEcCtD
Buprenorphine—Insomnia—Ramipril—coronary artery disease	3.6e-05	0.000244	CcSEcCtD
Buprenorphine—Dermatitis—Olmesartan—coronary artery disease	3.6e-05	0.000243	CcSEcCtD
Buprenorphine—Headache—Valsartan—coronary artery disease	3.6e-05	0.000243	CcSEcCtD
Buprenorphine—Diarrhoea—Telmisartan—coronary artery disease	3.59e-05	0.000243	CcSEcCtD
Buprenorphine—Infection—Lisinopril—coronary artery disease	3.59e-05	0.000243	CcSEcCtD
Buprenorphine—Headache—Olmesartan—coronary artery disease	3.58e-05	0.000242	CcSEcCtD
Buprenorphine—Paraesthesia—Ramipril—coronary artery disease	3.58e-05	0.000242	CcSEcCtD
Buprenorphine—Shock—Lisinopril—coronary artery disease	3.55e-05	0.00024	CcSEcCtD
Buprenorphine—Asthenia—Perindopril—coronary artery disease	3.55e-05	0.00024	CcSEcCtD
Buprenorphine—Dyspnoea—Ramipril—coronary artery disease	3.55e-05	0.00024	CcSEcCtD
Buprenorphine—Vomiting—Niacin—coronary artery disease	3.55e-05	0.00024	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Timolol—coronary artery disease	3.55e-05	0.00024	CcSEcCtD
Buprenorphine—Hypersensitivity—Furosemide—coronary artery disease	3.55e-05	0.00024	CcSEcCtD
Buprenorphine—Somnolence—Ramipril—coronary artery disease	3.54e-05	0.000239	CcSEcCtD
Buprenorphine—Dizziness—Trandolapril—coronary artery disease	3.53e-05	0.000239	CcSEcCtD
Buprenorphine—Tachycardia—Lisinopril—coronary artery disease	3.53e-05	0.000238	CcSEcCtD
Buprenorphine—Insomnia—Timolol—coronary artery disease	3.52e-05	0.000238	CcSEcCtD
Buprenorphine—Rash—Niacin—coronary artery disease	3.52e-05	0.000238	CcSEcCtD
Buprenorphine—Dermatitis—Niacin—coronary artery disease	3.52e-05	0.000238	CcSEcCtD
Buprenorphine—Dizziness—Enalapril—coronary artery disease	3.52e-05	0.000238	CcSEcCtD
Buprenorphine—Skin disorder—Lisinopril—coronary artery disease	3.51e-05	0.000237	CcSEcCtD
Buprenorphine—Dyspepsia—Ramipril—coronary artery disease	3.51e-05	0.000237	CcSEcCtD
Buprenorphine—Pruritus—Perindopril—coronary artery disease	3.5e-05	0.000237	CcSEcCtD
Buprenorphine—Headache—Niacin—coronary artery disease	3.5e-05	0.000237	CcSEcCtD
Buprenorphine—Paraesthesia—Timolol—coronary artery disease	3.5e-05	0.000236	CcSEcCtD
Buprenorphine—Vomiting—Pravastatin—coronary artery disease	3.5e-05	0.000236	CcSEcCtD
Buprenorphine—Hyperhidrosis—Lisinopril—coronary artery disease	3.49e-05	0.000236	CcSEcCtD
Buprenorphine—Diarrhoea—Captopril—coronary artery disease	3.49e-05	0.000236	CcSEcCtD
Buprenorphine—Dyspnoea—Timolol—coronary artery disease	3.47e-05	0.000235	CcSEcCtD
Buprenorphine—Dizziness—Telmisartan—coronary artery disease	3.47e-05	0.000235	CcSEcCtD
Buprenorphine—Rash—Pravastatin—coronary artery disease	3.47e-05	0.000234	CcSEcCtD
Buprenorphine—Dermatitis—Pravastatin—coronary artery disease	3.46e-05	0.000234	CcSEcCtD
Buprenorphine—Decreased appetite—Ramipril—coronary artery disease	3.46e-05	0.000234	CcSEcCtD
Buprenorphine—Somnolence—Timolol—coronary artery disease	3.46e-05	0.000234	CcSEcCtD
Buprenorphine—Asthenia—Furosemide—coronary artery disease	3.45e-05	0.000234	CcSEcCtD
Buprenorphine—Headache—Pravastatin—coronary artery disease	3.44e-05	0.000233	CcSEcCtD
Buprenorphine—Anorexia—Lisinopril—coronary artery disease	3.44e-05	0.000233	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Ramipril—coronary artery disease	3.44e-05	0.000232	CcSEcCtD
Buprenorphine—Fatigue—Ramipril—coronary artery disease	3.43e-05	0.000232	CcSEcCtD
Buprenorphine—Dyspepsia—Timolol—coronary artery disease	3.43e-05	0.000232	CcSEcCtD
Buprenorphine—Hypersensitivity—Losartan—coronary artery disease	3.42e-05	0.000231	CcSEcCtD
Buprenorphine—Nausea—Valsartan—coronary artery disease	3.41e-05	0.000231	CcSEcCtD
Buprenorphine—Pruritus—Furosemide—coronary artery disease	3.41e-05	0.00023	CcSEcCtD
Buprenorphine—Constipation—Ramipril—coronary artery disease	3.41e-05	0.00023	CcSEcCtD
Buprenorphine—Nausea—Olmesartan—coronary artery disease	3.39e-05	0.00023	CcSEcCtD
Buprenorphine—Vomiting—Trandolapril—coronary artery disease	3.39e-05	0.00023	CcSEcCtD
Buprenorphine—Diarrhoea—Perindopril—coronary artery disease	3.39e-05	0.000229	CcSEcCtD
Buprenorphine—Decreased appetite—Timolol—coronary artery disease	3.38e-05	0.000229	CcSEcCtD
Buprenorphine—Vomiting—Enalapril—coronary artery disease	3.38e-05	0.000229	CcSEcCtD
Buprenorphine—Hypotension—Lisinopril—coronary artery disease	3.38e-05	0.000228	CcSEcCtD
Buprenorphine—Dizziness—Captopril—coronary artery disease	3.37e-05	0.000228	CcSEcCtD
Buprenorphine—Rash—Trandolapril—coronary artery disease	3.37e-05	0.000228	CcSEcCtD
Buprenorphine—Dermatitis—Trandolapril—coronary artery disease	3.36e-05	0.000227	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Timolol—coronary artery disease	3.36e-05	0.000227	CcSEcCtD
Buprenorphine—Fatigue—Timolol—coronary artery disease	3.36e-05	0.000227	CcSEcCtD
Buprenorphine—Rash—Enalapril—coronary artery disease	3.35e-05	0.000227	CcSEcCtD
Buprenorphine—Dermatitis—Enalapril—coronary artery disease	3.35e-05	0.000226	CcSEcCtD
Buprenorphine—Headache—Trandolapril—coronary artery disease	3.34e-05	0.000226	CcSEcCtD
Buprenorphine—Vomiting—Telmisartan—coronary artery disease	3.33e-05	0.000225	CcSEcCtD
Buprenorphine—Asthenia—Losartan—coronary artery disease	3.33e-05	0.000225	CcSEcCtD
Buprenorphine—Headache—Enalapril—coronary artery disease	3.33e-05	0.000225	CcSEcCtD
Buprenorphine—Pain—Timolol—coronary artery disease	3.33e-05	0.000225	CcSEcCtD
Buprenorphine—Nausea—Niacin—coronary artery disease	3.32e-05	0.000224	CcSEcCtD
Buprenorphine—Rash—Telmisartan—coronary artery disease	3.31e-05	0.000224	CcSEcCtD
Buprenorphine—Dermatitis—Telmisartan—coronary artery disease	3.3e-05	0.000223	CcSEcCtD
Buprenorphine—Diarrhoea—Furosemide—coronary artery disease	3.29e-05	0.000223	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3.29e-05	0.000223	CcSEcCtD
Buprenorphine—Pruritus—Losartan—coronary artery disease	3.29e-05	0.000222	CcSEcCtD
Buprenorphine—Headache—Telmisartan—coronary artery disease	3.29e-05	0.000222	CcSEcCtD
Buprenorphine—Feeling abnormal—Ramipril—coronary artery disease	3.28e-05	0.000222	CcSEcCtD
Buprenorphine—Dizziness—Perindopril—coronary artery disease	3.27e-05	0.000221	CcSEcCtD
Buprenorphine—Insomnia—Lisinopril—coronary artery disease	3.27e-05	0.000221	CcSEcCtD
Buprenorphine—Nausea—Pravastatin—coronary artery disease	3.27e-05	0.000221	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Ramipril—coronary artery disease	3.26e-05	0.00022	CcSEcCtD
Buprenorphine—Paraesthesia—Lisinopril—coronary artery disease	3.24e-05	0.000219	CcSEcCtD
Buprenorphine—Vomiting—Captopril—coronary artery disease	3.24e-05	0.000219	CcSEcCtD
Buprenorphine—Dyspnoea—Lisinopril—coronary artery disease	3.22e-05	0.000218	CcSEcCtD
Buprenorphine—Rash—Captopril—coronary artery disease	3.22e-05	0.000217	CcSEcCtD
Buprenorphine—Dermatitis—Captopril—coronary artery disease	3.21e-05	0.000217	CcSEcCtD
Buprenorphine—Somnolence—Lisinopril—coronary artery disease	3.21e-05	0.000217	CcSEcCtD
Buprenorphine—Feeling abnormal—Timolol—coronary artery disease	3.21e-05	0.000217	CcSEcCtD
Buprenorphine—Headache—Captopril—coronary artery disease	3.2e-05	0.000216	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Timolol—coronary artery disease	3.18e-05	0.000215	CcSEcCtD
Buprenorphine—Dizziness—Furosemide—coronary artery disease	3.18e-05	0.000215	CcSEcCtD
Buprenorphine—Dyspepsia—Lisinopril—coronary artery disease	3.18e-05	0.000215	CcSEcCtD
Buprenorphine—Diarrhoea—Losartan—coronary artery disease	3.18e-05	0.000215	CcSEcCtD
Buprenorphine—Nausea—Trandolapril—coronary artery disease	3.17e-05	0.000214	CcSEcCtD
Buprenorphine—Urticaria—Ramipril—coronary artery disease	3.16e-05	0.000214	CcSEcCtD
Buprenorphine—Nausea—Enalapril—coronary artery disease	3.16e-05	0.000214	CcSEcCtD
Buprenorphine—Vomiting—Perindopril—coronary artery disease	3.15e-05	0.000213	CcSEcCtD
Buprenorphine—Body temperature increased—Ramipril—coronary artery disease	3.15e-05	0.000213	CcSEcCtD
Buprenorphine—Abdominal pain—Ramipril—coronary artery disease	3.15e-05	0.000213	CcSEcCtD
Buprenorphine—Decreased appetite—Lisinopril—coronary artery disease	3.14e-05	0.000212	CcSEcCtD
Buprenorphine—Rash—Perindopril—coronary artery disease	3.12e-05	0.000211	CcSEcCtD
Buprenorphine—Dermatitis—Perindopril—coronary artery disease	3.12e-05	0.000211	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Lisinopril—coronary artery disease	3.12e-05	0.000211	CcSEcCtD
Buprenorphine—Nausea—Telmisartan—coronary artery disease	3.12e-05	0.000211	CcSEcCtD
Buprenorphine—Fatigue—Lisinopril—coronary artery disease	3.11e-05	0.000211	CcSEcCtD
Buprenorphine—Headache—Perindopril—coronary artery disease	3.1e-05	0.00021	CcSEcCtD
Buprenorphine—Urticaria—Timolol—coronary artery disease	3.09e-05	0.000209	CcSEcCtD
Buprenorphine—Pain—Lisinopril—coronary artery disease	3.09e-05	0.000209	CcSEcCtD
Buprenorphine—Constipation—Lisinopril—coronary artery disease	3.09e-05	0.000209	CcSEcCtD
Buprenorphine—Body temperature increased—Timolol—coronary artery disease	3.08e-05	0.000208	CcSEcCtD
Buprenorphine—Abdominal pain—Timolol—coronary artery disease	3.08e-05	0.000208	CcSEcCtD
Buprenorphine—Dizziness—Losartan—coronary artery disease	3.07e-05	0.000208	CcSEcCtD
Buprenorphine—Vomiting—Furosemide—coronary artery disease	3.06e-05	0.000207	CcSEcCtD
Buprenorphine—Rash—Furosemide—coronary artery disease	3.04e-05	0.000205	CcSEcCtD
Buprenorphine—Dermatitis—Furosemide—coronary artery disease	3.03e-05	0.000205	CcSEcCtD
Buprenorphine—Nausea—Captopril—coronary artery disease	3.03e-05	0.000205	CcSEcCtD
Buprenorphine—Headache—Furosemide—coronary artery disease	3.02e-05	0.000204	CcSEcCtD
Buprenorphine—Feeling abnormal—Lisinopril—coronary artery disease	2.98e-05	0.000201	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Lisinopril—coronary artery disease	2.95e-05	0.0002	CcSEcCtD
Buprenorphine—Vomiting—Losartan—coronary artery disease	2.95e-05	0.0002	CcSEcCtD
Buprenorphine—Nausea—Perindopril—coronary artery disease	2.94e-05	0.000199	CcSEcCtD
Buprenorphine—Hypersensitivity—Ramipril—coronary artery disease	2.93e-05	0.000198	CcSEcCtD
Buprenorphine—Rash—Losartan—coronary artery disease	2.93e-05	0.000198	CcSEcCtD
Buprenorphine—Dermatitis—Losartan—coronary artery disease	2.93e-05	0.000198	CcSEcCtD
Buprenorphine—Headache—Losartan—coronary artery disease	2.91e-05	0.000197	CcSEcCtD
Buprenorphine—Urticaria—Lisinopril—coronary artery disease	2.87e-05	0.000194	CcSEcCtD
Buprenorphine—Hypersensitivity—Timolol—coronary artery disease	2.87e-05	0.000194	CcSEcCtD
Buprenorphine—Nausea—Furosemide—coronary artery disease	2.86e-05	0.000193	CcSEcCtD
Buprenorphine—Asthenia—Ramipril—coronary artery disease	2.86e-05	0.000193	CcSEcCtD
Buprenorphine—Abdominal pain—Lisinopril—coronary artery disease	2.86e-05	0.000193	CcSEcCtD
Buprenorphine—Body temperature increased—Lisinopril—coronary artery disease	2.86e-05	0.000193	CcSEcCtD
Buprenorphine—Pruritus—Ramipril—coronary artery disease	2.82e-05	0.000191	CcSEcCtD
Buprenorphine—Asthenia—Timolol—coronary artery disease	2.79e-05	0.000189	CcSEcCtD
Buprenorphine—Nausea—Losartan—coronary artery disease	2.76e-05	0.000187	CcSEcCtD
Buprenorphine—Pruritus—Timolol—coronary artery disease	2.75e-05	0.000186	CcSEcCtD
Buprenorphine—Diarrhoea—Ramipril—coronary artery disease	2.73e-05	0.000184	CcSEcCtD
Buprenorphine—Diarrhoea—Timolol—coronary artery disease	2.66e-05	0.00018	CcSEcCtD
Buprenorphine—Hypersensitivity—Lisinopril—coronary artery disease	2.66e-05	0.00018	CcSEcCtD
Buprenorphine—Dizziness—Ramipril—coronary artery disease	2.63e-05	0.000178	CcSEcCtD
Buprenorphine—Asthenia—Lisinopril—coronary artery disease	2.59e-05	0.000175	CcSEcCtD
Buprenorphine—Dizziness—Timolol—coronary artery disease	2.57e-05	0.000174	CcSEcCtD
Buprenorphine—Pruritus—Lisinopril—coronary artery disease	2.56e-05	0.000173	CcSEcCtD
Buprenorphine—Vomiting—Ramipril—coronary artery disease	2.53e-05	0.000171	CcSEcCtD
Buprenorphine—Rash—Ramipril—coronary artery disease	2.51e-05	0.00017	CcSEcCtD
Buprenorphine—Dermatitis—Ramipril—coronary artery disease	2.51e-05	0.00017	CcSEcCtD
Buprenorphine—Headache—Ramipril—coronary artery disease	2.5e-05	0.000169	CcSEcCtD
Buprenorphine—Vomiting—Timolol—coronary artery disease	2.48e-05	0.000167	CcSEcCtD
Buprenorphine—Diarrhoea—Lisinopril—coronary artery disease	2.47e-05	0.000167	CcSEcCtD
Buprenorphine—Rash—Timolol—coronary artery disease	2.45e-05	0.000166	CcSEcCtD
Buprenorphine—Dermatitis—Timolol—coronary artery disease	2.45e-05	0.000166	CcSEcCtD
Buprenorphine—Headache—Timolol—coronary artery disease	2.44e-05	0.000165	CcSEcCtD
Buprenorphine—Dizziness—Lisinopril—coronary artery disease	2.39e-05	0.000161	CcSEcCtD
Buprenorphine—Nausea—Ramipril—coronary artery disease	2.37e-05	0.00016	CcSEcCtD
Buprenorphine—Nausea—Timolol—coronary artery disease	2.31e-05	0.000156	CcSEcCtD
Buprenorphine—Vomiting—Lisinopril—coronary artery disease	2.3e-05	0.000155	CcSEcCtD
Buprenorphine—Rash—Lisinopril—coronary artery disease	2.28e-05	0.000154	CcSEcCtD
Buprenorphine—Dermatitis—Lisinopril—coronary artery disease	2.28e-05	0.000154	CcSEcCtD
Buprenorphine—Headache—Lisinopril—coronary artery disease	2.26e-05	0.000153	CcSEcCtD
Buprenorphine—Nausea—Lisinopril—coronary artery disease	2.15e-05	0.000145	CcSEcCtD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.73e-06	1.95e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—AKT1—coronary artery disease	1.73e-06	1.95e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CXCL8—coronary artery disease	1.73e-06	1.95e-05	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.72e-06	1.95e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.72e-06	1.95e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SERPINE1—coronary artery disease	1.72e-06	1.95e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GSTM1—coronary artery disease	1.72e-06	1.94e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GGT1—coronary artery disease	1.71e-06	1.93e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GOT1—coronary artery disease	1.71e-06	1.93e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—NOS3—coronary artery disease	1.71e-06	1.93e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GOT1—coronary artery disease	1.69e-06	1.91e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GGT1—coronary artery disease	1.69e-06	1.91e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CTGF—coronary artery disease	1.69e-06	1.91e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—NOS3—coronary artery disease	1.69e-06	1.91e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—LPL—coronary artery disease	1.69e-06	1.91e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—HMGCR—coronary artery disease	1.68e-06	1.89e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GOT2—coronary artery disease	1.68e-06	1.89e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GSTP1—coronary artery disease	1.67e-06	1.89e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—FGF2—coronary artery disease	1.67e-06	1.88e-05	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—AKT1—coronary artery disease	1.67e-06	1.88e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—AGT—coronary artery disease	1.67e-06	1.88e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	1.65e-06	1.87e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CASP3—coronary artery disease	1.65e-06	1.87e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—HMOX1—coronary artery disease	1.65e-06	1.86e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GPX1—coronary artery disease	1.65e-06	1.86e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NOS3—coronary artery disease	1.64e-06	1.86e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL6—coronary artery disease	1.64e-06	1.85e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—APOE—coronary artery disease	1.63e-06	1.84e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GSTP1—coronary artery disease	1.63e-06	1.84e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—VCAN—coronary artery disease	1.62e-06	1.84e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CAT—coronary artery disease	1.62e-06	1.83e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ALB—coronary artery disease	1.62e-06	1.83e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PPARGC1A—coronary artery disease	1.61e-06	1.82e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—APOA1—coronary artery disease	1.61e-06	1.82e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.61e-06	1.82e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCND1—coronary artery disease	1.61e-06	1.82e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—HMOX1—coronary artery disease	1.61e-06	1.81e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CD36—coronary artery disease	1.6e-06	1.81e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—VEGFA—coronary artery disease	1.6e-06	1.81e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—JAK2—coronary artery disease	1.6e-06	1.81e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CAT—coronary artery disease	1.58e-06	1.79e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PPP2CA—coronary artery disease	1.58e-06	1.79e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—APOB—coronary artery disease	1.58e-06	1.78e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—PIK3CA—coronary artery disease	1.57e-06	1.77e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—DCN—coronary artery disease	1.56e-06	1.77e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MMP9—coronary artery disease	1.56e-06	1.76e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTGS2—coronary artery disease	1.56e-06	1.76e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—NOS3—coronary artery disease	1.55e-06	1.75e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTGS2—coronary artery disease	1.55e-06	1.75e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PLCB1—coronary artery disease	1.54e-06	1.74e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—APOB—coronary artery disease	1.54e-06	1.74e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GSTP1—coronary artery disease	1.53e-06	1.73e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GSTM1—coronary artery disease	1.53e-06	1.73e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.52e-06	1.72e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GSTP1—coronary artery disease	1.52e-06	1.72e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	1.52e-06	1.72e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MTHFR—coronary artery disease	1.52e-06	1.72e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—AKT1—coronary artery disease	1.51e-06	1.71e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—HMOX1—coronary artery disease	1.51e-06	1.71e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.51e-06	1.71e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	1.51e-06	1.7e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—LPL—coronary artery disease	1.51e-06	1.7e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—HMOX1—coronary artery disease	1.5e-06	1.7e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GSTM1—coronary artery disease	1.5e-06	1.69e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ABCA1—coronary artery disease	1.49e-06	1.69e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CAT—coronary artery disease	1.49e-06	1.69e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.48e-06	1.68e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.48e-06	1.68e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—LIPC—coronary artery disease	1.48e-06	1.68e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—HBA1—coronary artery disease	1.48e-06	1.68e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CAT—coronary artery disease	1.48e-06	1.67e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOC3—coronary artery disease	1.47e-06	1.67e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—LPL—coronary artery disease	1.47e-06	1.66e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GPX1—coronary artery disease	1.47e-06	1.66e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TGFB1—coronary artery disease	1.47e-06	1.66e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—LDLR—coronary artery disease	1.47e-06	1.66e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCL8—coronary artery disease	1.46e-06	1.65e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—APOB—coronary artery disease	1.45e-06	1.64e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.45e-06	1.64e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.45e-06	1.64e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GOT1—coronary artery disease	1.45e-06	1.64e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GGT1—coronary artery disease	1.45e-06	1.64e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—AGT—coronary artery disease	1.44e-06	1.63e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MAPK1—coronary artery disease	1.44e-06	1.63e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—APOB—coronary artery disease	1.44e-06	1.62e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GPX1—coronary artery disease	1.43e-06	1.62e-05	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PIK3CA—coronary artery disease	1.43e-06	1.62e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CETP—coronary artery disease	1.43e-06	1.62e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GCLC—coronary artery disease	1.43e-06	1.62e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CD36—coronary artery disease	1.43e-06	1.62e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PPARG—coronary artery disease	1.42e-06	1.61e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTGS2—coronary artery disease	1.42e-06	1.6e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SDC1—coronary artery disease	1.42e-06	1.6e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—APOE—coronary artery disease	1.41e-06	1.6e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PPP2CA—coronary artery disease	1.41e-06	1.6e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GSTM1—coronary artery disease	1.41e-06	1.59e-05	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—AKT1—coronary artery disease	1.41e-06	1.59e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—POMC—coronary artery disease	1.4e-06	1.58e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—VEGFA—coronary artery disease	1.4e-06	1.58e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GSTM1—coronary artery disease	1.4e-06	1.58e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—APOA1—coronary artery disease	1.4e-06	1.58e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CASP3—coronary artery disease	1.4e-06	1.58e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CD36—coronary artery disease	1.4e-06	1.58e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6—coronary artery disease	1.39e-06	1.57e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—LPL—coronary artery disease	1.38e-06	1.56e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.38e-06	1.56e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—LPL—coronary artery disease	1.37e-06	1.55e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCND1—coronary artery disease	1.36e-06	1.54e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MTHFR—coronary artery disease	1.36e-06	1.53e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GPX1—coronary artery disease	1.35e-06	1.53e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GPX1—coronary artery disease	1.34e-06	1.51e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.34e-06	1.51e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.34e-06	1.51e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.34e-06	1.51e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MTHFR—coronary artery disease	1.32e-06	1.49e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MMP9—coronary artery disease	1.32e-06	1.49e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CD36—coronary artery disease	1.32e-06	1.49e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CTGF—coronary artery disease	1.31e-06	1.48e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CD36—coronary artery disease	1.3e-06	1.47e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GSTP1—coronary artery disease	1.3e-06	1.47e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.3e-06	1.47e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.29e-06	1.46e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GOT2—coronary artery disease	1.29e-06	1.46e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.29e-06	1.46e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.29e-06	1.46e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—AGT—coronary artery disease	1.29e-06	1.45e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TGFB1—coronary artery disease	1.29e-06	1.45e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.28e-06	1.45e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—AKT1—coronary artery disease	1.28e-06	1.45e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ALB—coronary artery disease	1.28e-06	1.44e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CAT—coronary artery disease	1.27e-06	1.43e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MAPK1—coronary artery disease	1.26e-06	1.43e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—APOE—coronary artery disease	1.26e-06	1.43e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—AGT—coronary artery disease	1.26e-06	1.42e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PIK3CA—coronary artery disease	1.25e-06	1.41e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—APOA1—coronary artery disease	1.25e-06	1.41e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.25e-06	1.41e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.24e-06	1.4e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—APOE—coronary artery disease	1.23e-06	1.39e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PPARG—coronary artery disease	1.23e-06	1.39e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOB—coronary artery disease	1.23e-06	1.39e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—NOS3—coronary artery disease	1.22e-06	1.38e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—APOA1—coronary artery disease	1.22e-06	1.38e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—POMC—coronary artery disease	1.21e-06	1.37e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.19e-06	1.35e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.19e-06	1.35e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.19e-06	1.34e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—VEGFA—coronary artery disease	1.18e-06	1.34e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—AGT—coronary artery disease	1.18e-06	1.34e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—AGT—coronary artery disease	1.17e-06	1.33e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—LPL—coronary artery disease	1.17e-06	1.33e-05	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—AKT1—coronary artery disease	1.17e-06	1.32e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—APOE—coronary artery disease	1.16e-06	1.31e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.15e-06	1.3e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—APOE—coronary artery disease	1.15e-06	1.3e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—APOA1—coronary artery disease	1.15e-06	1.3e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GPX1—coronary artery disease	1.14e-06	1.29e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—APOA1—coronary artery disease	1.14e-06	1.28e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PIK3CA—coronary artery disease	1.13e-06	1.28e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTGS2—coronary artery disease	1.12e-06	1.26e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GOT1—coronary artery disease	1.12e-06	1.26e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GGT1—coronary artery disease	1.12e-06	1.26e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CD36—coronary artery disease	1.11e-06	1.26e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ALB—coronary artery disease	1.11e-06	1.25e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6—coronary artery disease	1.11e-06	1.25e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.1e-06	1.24e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PPARG—coronary artery disease	1.1e-06	1.24e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PIK3CA—coronary artery disease	1.09e-06	1.24e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.09e-06	1.23e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TGFB1—coronary artery disease	1.09e-06	1.23e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—POMC—coronary artery disease	1.08e-06	1.22e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PPARG—coronary artery disease	1.07e-06	1.21e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MAPK1—coronary artery disease	1.07e-06	1.2e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—NOS3—coronary artery disease	1.06e-06	1.2e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—POMC—coronary artery disease	1.06e-06	1.2e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.06e-06	1.19e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—AKT1—coronary artery disease	1.02e-06	1.15e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PPARG—coronary artery disease	1.01e-06	1.14e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GSTP1—coronary artery disease	1e-06	1.13e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—AGT—coronary artery disease	1e-06	1.13e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PPARG—coronary artery disease	1e-06	1.13e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—POMC—coronary artery disease	9.97e-07	1.13e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	9.94e-07	1.12e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—HMOX1—coronary artery disease	9.9e-07	1.12e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—POMC—coronary artery disease	9.88e-07	1.12e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ALB—coronary artery disease	9.88e-07	1.12e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOE—coronary artery disease	9.83e-07	1.11e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CAT—coronary artery disease	9.76e-07	1.1e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOA1—coronary artery disease	9.72e-07	1.1e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6—coronary artery disease	9.7e-07	1.1e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGS2—coronary artery disease	9.69e-07	1.09e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ALB—coronary artery disease	9.65e-07	1.09e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PIK3CA—coronary artery disease	9.6e-07	1.08e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PIK3CA—coronary artery disease	9.52e-07	1.08e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOB—coronary artery disease	9.48e-07	1.07e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—NOS3—coronary artery disease	9.45e-07	1.07e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	9.31e-07	1.05e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PIK3CA—coronary artery disease	9.25e-07	1.05e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—AKT1—coronary artery disease	9.24e-07	1.04e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—NOS3—coronary artery disease	9.23e-07	1.04e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GSTM1—coronary artery disease	9.22e-07	1.04e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ALB—coronary artery disease	9.09e-07	1.03e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—LPL—coronary artery disease	9.05e-07	1.02e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ALB—coronary artery disease	9.01e-07	1.02e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—AKT1—coronary artery disease	8.94e-07	1.01e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GPX1—coronary artery disease	8.83e-07	9.98e-06	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PIK3CA—coronary artery disease	8.72e-07	9.86e-06	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—NOS3—coronary artery disease	8.69e-07	9.82e-06	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS2—coronary artery disease	8.65e-07	9.77e-06	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—NOS3—coronary artery disease	8.62e-07	9.74e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CD36—coronary artery disease	8.6e-07	9.72e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PPARG—coronary artery disease	8.56e-07	9.68e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	8.49e-07	9.6e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—POMC—coronary artery disease	8.45e-07	9.54e-06	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS2—coronary artery disease	8.44e-07	9.53e-06	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6—coronary artery disease	8.19e-07	9.26e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MTHFR—coronary artery disease	8.15e-07	9.21e-06	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS2—coronary artery disease	7.95e-07	8.98e-06	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS2—coronary artery disease	7.88e-07	8.91e-06	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—AKT1—coronary artery disease	7.84e-07	8.86e-06	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—AKT1—coronary artery disease	7.78e-07	8.79e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—AGT—coronary artery disease	7.74e-07	8.75e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ALB—coronary artery disease	7.7e-07	8.7e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOE—coronary artery disease	7.59e-07	8.57e-06	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—AKT1—coronary artery disease	7.56e-07	8.54e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOA1—coronary artery disease	7.5e-07	8.47e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—NOS3—coronary artery disease	7.37e-07	8.32e-06	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—AKT1—coronary artery disease	7.13e-07	8.05e-06	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PIK3CA—coronary artery disease	6.88e-07	7.77e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS2—coronary artery disease	6.74e-07	7.61e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PPARG—coronary artery disease	6.61e-07	7.47e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—POMC—coronary artery disease	6.52e-07	7.36e-06	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PIK3CA—coronary artery disease	5.96e-07	6.73e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ALB—coronary artery disease	5.94e-07	6.71e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NOS3—coronary artery disease	5.68e-07	6.42e-06	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—AKT1—coronary artery disease	5.62e-07	6.35e-06	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PIK3CA—coronary artery disease	5.32e-07	6.01e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS2—coronary artery disease	5.2e-07	5.87e-06	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PIK3CA—coronary artery disease	5.19e-07	5.87e-06	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	4.89e-07	5.53e-06	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—AKT1—coronary artery disease	4.87e-07	5.5e-06	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PIK3CA—coronary artery disease	4.85e-07	5.48e-06	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—AKT1—coronary artery disease	4.35e-07	4.91e-06	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—AKT1—coronary artery disease	4.24e-07	4.79e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	4.14e-07	4.68e-06	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—AKT1—coronary artery disease	4e-07	4.52e-06	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—AKT1—coronary artery disease	3.96e-07	4.48e-06	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—AKT1—coronary artery disease	3.39e-07	3.83e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	3.2e-07	3.61e-06	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—AKT1—coronary artery disease	2.61e-07	2.95e-06	CbGpPWpGaD
